U.S. Markets close in 22 mins.

Heska Corporation (HSKA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
88.46-5.53 (-5.89%)
As of 3:34PM EDT. Market open.
People also watch
ICCCANIKIARTIDXXCGEN

Heska Corporation

3760 Rocky Mountain Avenue
Loveland, CO 80538
United States
970-493-7272
http://www.heska.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees327

Key Executives

NameTitlePayExercisedAge
Mr. Kevin S. WilsonChief Exec. Officer, Pres and Director282.81kN/A45
Mr. John McMahon CPAChief Financial Officer and VP406.58k131.03k52
Mr. Jason A. NapolitanoChief Operating Officer, Chief Strategist and Sec.523.8k619.92k49
Mr. Steven M. EylExec. VP of Global Sales and Marketing414.89kN/A51
Dr. Nancy Wisnewski Ph.D.Exec. VP of Diagnostic Operations and Product Devel.390.1k374.95k54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. It operates through two segments, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus Chewable Tablets for the preventive treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels. The Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. The company sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.

Corporate Governance

Heska Corporation’s ISS Governance QualityScore as of September 1, 2017 is 6. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 7; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.